Table 1.

Men with Symptomatic Urethritis

	MSM (N=40)	MSF (N=79)	P value (0.094)
Age
Average	34 ±12.2	32 ±10.1	0.344
Range	16–31	16–58
Race
Asian	5% (2)	3% (2)	1.000
Black or African American	23% (9)	27% (21)	0.663
White/Caucasian	64.3% (26)	57% (45)	0.435
Other	8% (3)	5% (4)	0.686
Ethnicity
Hispanic or Latino	3% (1)	27% (21)	0.001
Health Coverage
Medically Insured	23% (9)	18% (14)	0.624
Self-assessed risk of contracting HIV
Low	20% (8)	37% (29)	0.093
Medium	28% (11)	10% (8)	0.019
High	8% (3)	3% (2)	0.333
(+) HIV test in the past	25% (10)	1% (1)	<0.001
Sexual Behavior
100% Condom use for anal/ vaginal sex	10% (4)	25% (20)	0.056
Total sex partners in 12 months	9.4 ±13.2	3.6 ±3.2	<0.001
Partners known to have HIV/ IV Drug use	23% (9)	0% (0)	<0.001
Number of partners with unprotected sex	7.5 ±13.8	2.0 ±2.5	<0.001
STI in past the past 12 months	20% (8)	11% (9)	0.268
Lifetime incidence of an STI	45% (18)	39% (31)	0.561
Injection drug use	10% (4)	1% (1)	0.043
Average days with symptoms before evaluation	17 ±44.9	35 ±77.
Symptoms
Dysuria	70% (28)	66% (52)	0.685
Irritative urinary symptoms	1% (2)	15% (12)	0.137
Discharge	50% (20)	46% (36)	0.700
Dyspareunia	0% (0)	3% (2)	0.550
Urinary frequency	8% (3)	4% (3)	0.403
Urine PCR
(+) Gonorrhea	25% (10)	6% (5)	0.007
(+) Chlamydia	20% (8)	30% (24)	0.277
NGNCU	60% (24)	65% (51)	0.690

MSM, men who have sex with men

MSF, men who have sex with women only

HIV, human immunodeficiency virus

STI, sexually transmitted infection

PCR, polymerase chain reaction (described in methods)

NGNCU, non-gonorrheal non-chlamydial urethritis